Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

For nearly three decades, children from Pennsylvania and surrounding states living with or affected by HIV have been ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

HIV self-testing is proving to be a revolutionary tool in Mizoram's fight against HIV/AIDS, offering a more private, convenient and effective means of diagnosis, the Health Ministry said on Tuesday.

The Week is part of Future US Inc, an international media group and leading digital publisher. Visit our corporate site.

34,691 people played the daily Crossword recently. Can you solve it faster than others?34,691 people played the daily Crossword recently. Can you solve it faster than others?

US President Donald Trump’s recent executive order to freeze USAID’s funding means Nyumbani’s access to life-saving antiretroviral drugs, which stop the HIV virus from replicating in the ...